Save Recarbrio as a Last Resort for Resistant Infections

Recarbrio (reh-CAR-bree-oh, imipenem/cilastatin/relebactam) is a new combo antibiotic for resistant gram-negative infections.

It follows in the footsteps of other novel, broad-spectrum beta-lactamase inhibitor combos...such as Vabomere (meropenem/vaborbactam) and Avycaz (ceftazidime/avibactam).

Relebactam is a beta-lactamase inhibitor that restores imipenem's activity against organisms, such as resistant Pseudomonas or common carbapenem-resistant Enterobacteriaceae (CRE).

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals